Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,927 | 20 | 57.0% |
| Travel and Lodging | $6,788 | 22 | 20.5% |
| Consulting Fee | $5,609 | 7 | 16.9% |
| Food and Beverage | $1,868 | 29 | 5.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $8,160 | 14 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $6,568 | 8 | $0 (2023) |
| GENZYME CORPORATION | $5,435 | 9 | $0 (2023) |
| ABBVIE INC. | $5,295 | 16 | $0 (2024) |
| Genmab U.S., Inc. | $2,663 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,240 | 4 | $0 (2022) |
| Celgene Corporation | $2,160 | 9 | $0 (2023) |
| Incyte Corporation | $365.00 | 1 | $0 (2021) |
| BeiGene USA, Inc. | $157.14 | 2 | $0 (2024) |
| TG THERAPEUTICS, INC. | $148.59 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,807 | 26 | ABBVIE INC. ($3,591) |
| 2023 | $7,934 | 15 | Pharmacyclics LLC, An AbbVie Company ($4,278) |
| 2022 | $14,825 | 28 | Janssen Biotech, Inc. ($6,173) |
| 2021 | $3,627 | 9 | Janssen Biotech, Inc. ($1,488) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $113.34 | General |
| Category: Oncology | ||||||
| 06/04/2024 | ABBVIE INC. | EPKINLY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | EPKINLY (Drug) | Travel and Lodging | In-kind items and services | $499.20 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | EPKINLY (Drug) | Travel and Lodging | In-kind items and services | $453.75 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | EPKINLY (Drug) | Travel and Lodging | In-kind items and services | $214.55 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | EPKINLY (Drug) | Travel and Lodging | In-kind items and services | $159.87 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $115.25 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Oncology | ||||||
| 05/14/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: Oncology | ||||||
| 04/16/2024 | ABBVIE INC. | EPKINLY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $337.50 | General |
| Category: ONCOLOGY | ||||||
| 03/20/2024 | Genmab U.S., Inc. | — | Travel and Lodging | Cash or cash equivalent | $117.06 | General |
| 03/19/2024 | Genmab U.S., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,312.50 | General |
| 03/19/2024 | Genmab U.S., Inc. | — | Food and Beverage | Cash or cash equivalent | $52.55 | General |
| 03/19/2024 | Genmab U.S., Inc. | — | Travel and Lodging | Cash or cash equivalent | $50.50 | General |
| 03/19/2024 | Genmab U.S., Inc. | — | Food and Beverage | In-kind items and services | $28.43 | General |
| 03/19/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Oncology | ||||||
| 03/19/2024 | Genmab U.S., Inc. | — | Food and Beverage | Cash or cash equivalent | $21.88 | General |
| 03/19/2024 | Genmab U.S., Inc. | — | Food and Beverage | In-kind items and services | $16.14 | General |
| 03/18/2024 | Genmab U.S., Inc. | — | Travel and Lodging | In-kind items and services | $429.40 | General |
| 03/18/2024 | Genmab U.S., Inc. | — | Travel and Lodging | In-kind items and services | $252.35 | General |
| 03/18/2024 | Genmab U.S., Inc. | — | Travel and Lodging | Cash or cash equivalent | $98.70 | General |
| 03/18/2024 | Genmab U.S., Inc. | — | Food and Beverage | Cash or cash equivalent | $39.23 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 73 | 169 | $78,119 | $14,146 |
| 2022 | 2 | 86 | 179 | $86,747 | $16,575 |
| 2021 | 3 | 125 | 330 | $144,685 | $30,738 |
| 2020 | 3 | 113 | 268 | $106,838 | $18,140 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 30 | 89 | $50,207 | $8,936 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 43 | 80 | $27,912 | $5,210 | 18.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 52 | 133 | $71,285 | $13,688 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 34 | 46 | $15,462 | $2,886 | 18.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 63 | 202 | $105,118 | $21,760 | 20.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 51 | 116 | $37,563 | $8,290 | 22.1% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 11 | 12 | $2,004 | $688.32 | 34.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 47 | 133 | $66,597 | $10,662 | 16.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 52 | 121 | $37,915 | $6,647 | 17.5% |
| 38222 | Bone marrow biopsy and aspiration | Facility | 2020 | 14 | 14 | $2,326 | $830.90 | 35.7% |
About Jacklyn Gideon
Jacklyn Gideon is a Adult Health healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2017. The National Provider Identifier (NPI) number assigned to this provider is 1629515572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jacklyn Gideon has received a total of $33,192 in payments from pharmaceutical and medical device companies, with $6,807 received in 2024. These payments were reported across 78 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,927).
As a Medicare-enrolled provider, Gideon has provided services to 397 Medicare beneficiaries, totaling 946 services with total Medicare billing of $79,599. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Chicago, IL
- Active Since 01/30/2017
- Last Updated 10/24/2022
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1629515572
Products in Payments
- IMBRUVICA (Drug) $14,728
- ELITEK (Biological) $5,435
- EPKINLY (Drug) $3,591
- Revlimid (Drug) $335.00
- Epkinly (Drug) $244.61
- BRUKINSA (Drug) $157.14
- UKONIQ (Drug) $148.59
- Pomalyst (Drug) $24.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Chicago
Maurice Brownlee, Aprn, APRN
Adult Health — Payments: $110,477
Nicole Tasker, Fnp-Bc, FNP-BC
Adult Health — Payments: $110,217
Colleen Folkers, Anp-Bc, ANP-BC
Adult Health — Payments: $63,728
Michelle Munroe, Apn-Cnp, APN-CNP
Adult Health — Payments: $32,338
Tammy Poma
Adult Health — Payments: $31,681
Jennifer Greenfield, Apn, APN
Adult Health — Payments: $26,444